FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

PMA: P160039 · Supplement: S005 · Decision Dec 23, 2019
Classifications
1
FEI Numbers
3
Registration Numbers
3

Basic Information

Device Name
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
Trade Name
remede® System
PMA Number
P160039
Supplement Number
S005
Device Class
FDA Class 3
Product Code
PSR
Generic Name
Implanted phrenic nerve stimulator for central sleep apnea
Medical Specialty
Unknown
Advisory Committee
Anesthesiology
Decision
Approved
Decision Code
APPR
Decision Date
December 23, 2019
Date Received
August 20, 2019
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for software changes to the Model 7001 Remede Reports Application and the addition of Respistim LQ/LQS stimulation lead models to the family of respistim L (left) leads.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PSR Implanted Phrenic Nerve Stimulator For Central Sleep Apnea